Latest Options Exercise News

Scalare Partners has locked in a $5 million convertible note facility from Blackstone Mercantile, paving the way for up to $25 million in funding subject to shareholder approval. The deal includes a 60:1 share consolidation and a bonus option issue designed to soften dilution for existing shareholders.

Many Peaks Minerals has exercised its option to acquire 100% of the Baga Gold Project in Côte d'Ivoire after a comprehensive soil sampling campaign revealed extensive gold anomalies. A 14,000m auger drilling program is now testing multiple targets along a 16km gold corridor.

American Tungsten & Antimony Ltd has inked an underwriting deal with GBA Capital to ensure full subscription of up to 69 million AT4N options expiring this month, securing potential capital injection amid its US critical minerals push.

Taiton Resources has issued nearly 1.8 million shares and close to 900,000 options to a sophisticated investor, part of an ongoing placement raising $125,000 so far. Additional shares and options will follow as funds come in.

Macarthur Minerals narrowed its loss to $1.82 million for FY26, bolstered by a major new investor and joint venture at its Lake Giles iron ore project in Western Australia.

Sprintex Limited has locked in underwriting agreements covering 8.7 million unexercised options, potentially raising up to A$870,000. The company also agreed to extend a A$1.85 million convertible note maturity by one year, pending shareholder approval.

HITIQ Limited has secured $1.4 million through a private placement of 200 million shares at 0.7 cents each, accompanied by options exercisable until 2029. The capital will bolster its balance sheet and back expansion and commercialisation efforts.

Toubani Resources (ASX: TRE) is acquiring a near 20% equity interest in Avanti Gold (CSE: AGC) via a share swap, gaining exposure to the Misisi Gold Project in the DRC with a 3.1 million ounce inferred resource.

Theta Gold Mines has secured US$18.6 million via placement and options exercise, completing equity funding for its US$90 million bond and advancing the TGME Gold Mine towards first production in early 2027.

Recce Pharmaceuticals secured A$4 million through an institutional placement and launched a Share Purchase Plan to raise up to an additional A$4 million, bolstering funds for commercial licensing and ongoing clinical programs.

1414 Degrees offers bonus Loyalty Options to shareholders alongside a $8.45 million capital raise aimed at advancing its clean energy projects, including the Aurora Energy Precinct and SiNTL commercialisation.

Imagion Biosystems has raised $3.75 million to fund the start of its Phase 1b/2 clinical trial for the MagSense HER2 imaging agent in the US, following FDA clearance. The capital raising involves a two-tranche share placement with free attaching options, led by CPS Capital.